Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
37m
on MSN
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Daily
33m
FDA approves Semaglutide for renal protection among diabetes patients with CKD
Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...
55m
on MSN
Sam Altman's India visit next week: why it is significant
OpenAI was openly challenged by Chinese startup DeepSeek in the AI arena, which the ChatGPT maker has commanded since 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
FDA upgrades recall
Gets 11 years in prison
OK school citizenship rule
Lay's potato chips recall
Denver schools face probe
CO military base for ICE use
Security detail revoked
ICC sanctions bill blocked
Approved for kidney disease
'The Voice' alum dies at 44
Cutting corporate workforce
Email privacy lawsuit filed
Senate confirmation hearing
1st Latina, Black AZ justice
Drops classified docs case
Recalls chicken nuggets
To recall 290K+ vehicles
NC inmate escapes
Fall behind in reading
Hush money conviction appeal
To lay off 234 workers
Pushes for earlier trial
Signs Laken Riley Act
Record trade deficit in goods
To hold migrants
Agrees to settle Trump suit
OpenAI probing DeepSeek
Rescinds freeze on grants
Related topics
Ozempic
Novo Nordisk
Wegovy
thyroid cancer
Eli Lilly
Feedback